Evidence map›Paper›PMID 41803767›Full record

ArticleBMC infectious diseases2026

Non-tuberculous Mycobacterial pulmonary disease due to novel mycobacterium: Mycobacterium habikinoensis: a case report.

Kyohei Maeda, Yoshitaka Tamura, Yuta Nagai, Yuki Kariya, Hiroki Katsuta, Naoko Ajiro, Hiroko Yoshida, Yuki Han, Shoji Hashimoto, Kinuyo Chikamatsu and 8 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Kyohei MaedaDepartment of Infectious Diseases, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan. m14102km@jichi.ac.jp.
Yoshitaka TamuraDepartment of Infectious Diseases, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.
Yuta NagaiDepartment of Infectious Diseases, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.
Yuki KariyaDepartment of Infectious Diseases, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.
Hiroki KatsutaDepartment of Clinical Laboratory, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.
Naoko AjiroDepartment of Clinical Laboratory, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.
Hiroko YoshidaDepartment of Clinical Laboratory, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.
Yuki HanDepartment of Infectious Diseases, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.
Shoji HashimotoDepartment of Infectious Diseases, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.
Kinuyo ChikamatsuResearch Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Matsuyama, Kiyose, Tokyo, 3-1-24, Japan.
Akiko TakakiResearch Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Matsuyama, Kiyose, Tokyo, 3-1-24, Japan.
Yuki MatsumotoDepartment of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), Osaka University, 3-1 Yamadaoka, Suita, Osaka, Japan.
Rizky Mutiara FatimahDepartment of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), Osaka University, 3-1 Yamadaoka, Suita, Osaka, Japan.
Michio TanakaPathogenic Microbes Repository Unit, Research Institute for Microbial Disease (RIMD), Osaka University, 3-1 Yamadaoka, Suita, Osaka, Japan.
Shota NakamuraDepartment of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), Osaka University, 3-1 Yamadaoka, Suita, Osaka, Japan.
Tetsuya IidaPathogenic Microbes Repository Unit, Research Institute for Microbial Disease (RIMD), Osaka University, 3-1 Yamadaoka, Suita, Osaka, Japan.
Satoshi MitaraiResearch Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Matsuyama, Kiyose, Tokyo, 3-1-24, Japan.
Takayuki NagaiDepartment of Infectious Diseases, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino-city, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of non-tuberculous mycobacterial pulmonary disease (NTM-PD) is increasing, and the identification of new Mycobacterium species is also increasing. We describe the first case of chronic pulmonary infection caused by a novel Mycobacterium species. CASE PRESENTATION: A 66-year-old man was referred to our hospital with a several-week history of low-grade fever and productive cough. An acid-fast bacillus smear test of the sputum revealed positive. Polymerase chain reaction (PCR) for Mycobacterium intracellulare was positive; however, Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) failed to identify the strain. The isolated culture was referred for further genotypic identification and was confirmed to be a novel species. Combination therapy with clarithromycin, rifampicin, and sitafloxacin was started. Despite treatment, the patient’s condition gradually worsened during the subsequent follow-up period.

conclusionsWe describe the first case of NTM-PD with a novel Mycobacterium species. Mycobacterium habikinoensis is a novel species closely related to Mycobacterium colombiense but with distinct characteristics. Further investigation is required to clarify its pathogenicity, antimicrobial susceptibility, and clinical significance in human infections.

Indexed as

Lung DiseasesMycobacteriumMycobacterium Infections, NontuberculousNontuberculous MycobacteriaAgedAnti-Bacterial AgentsBacilloscopyHumansMaleSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSputumAnti-Bacterial AgentsHuman pathogenMycobacteriumMycobacterium habikinoensisNext-generation sequencingNon-tuberculous mycobacteriaWhole-genome analysis

Identifiers

PMID41803767
PMCPMC13085733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.